Source: Health Sciences Authority (SG) Revision Year: 2021 Publisher: SMB Technology S.A., Rue du Parc Industriel 39, B-6900 Marche en Famenne, Belgium
Pravafen 40 mg/160 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Hard capsule. Pravafen is a hard capsule, with light green body and olive cap, containing a waxy white beige mass and a tablet. |
Each hard capsule contains 40 mg pravastatin sodium and 160 mg fenofibrate.
Excipient(s) with known effect: Each hard capsule contains 19 mg of lactose monohydrate.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Fenofibrate |
Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type α (PPARα). Through activation of PPARα, fenofibrate increases lipolysis and elimination of atherogenic triglyceride rich particles from plasma by activating lipoprotein lipase and reducing production of Apoprotein C-III. |
|
| Pravastatin |
Pravastatin is a competitive inhibitor of 3-hydroxy–3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme catalyzing the early rate limiting step in cholesterol biosynthesis, and produces its lipid lowering effect in two ways. |
| List of Excipients |
|---|
|
Capsule content: Lactose monohydrate Capsule shell: Gelatine |
Opaque white HDPE bottles containing 30 hard capsules.
SMB Technology S.A., Rue du Parc Industriel 39, B-6900 Marche en Famenne, Belgium
| Drug | Countries | |
|---|---|---|
| PRAVAFEN | Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
